Knight Therapeutics | GUD - Lucro Operacional

Preço das Ações
6.16
Mudança Diária
-0.06 -0.96%
Mensal
3.53%
Anual
12.41%
Q1 Previsão
6.12




Lucro Operacional Alterar Data
Acasti Pharma USD -2.53M 560K 2025-09
Akebia Therapeutics USD 13.51M 27.82M 2025-03
Alaunos Therapeutics USD -1.19M 432K 2025-09
Aurora Cannabis CAD -55.67M 35.45M 2025-09
Avita Medical AUD -10.41M 742K 2025-12
Canopy Growth CAD -14.3M 3.18M 2025-09
Cronos Group USD -7.06M 62.31M 2025-12
Dianthus Therapeutics USD -40.29M 5.36M 2025-09
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Knight Therapeutics CAD 3.2M 1.29M 2024-09
Moderna USD -857M 597M 2025-12
Omeros USD -35.41M 23.75M 2024-09
Organigram Holdings CAD -28.05M 7.76M 2025-09
Organon & Co USD 388M 62M 2025-09
Revvity USD 145.83M 47.49M 2025-12
Tectonic Therapeutic USD -21.89M 440K 2025-09
Tilray USD -20.01M 9.34M 2025-09
Viatris USD -157.5M 392M 2025-12
Xeris Pharmaceuticals USD 6.73M 2.25M 2025-09